Search Counselor
Login
Current Issue
| The Unique Challenges of Treating Addicted Healthcare Professionals |
|
|
| Feature Articles - Professional Ethics | ||||||||||||||||||||||||||||||||||
| Monday, 29 March 2010 10:36 | ||||||||||||||||||||||||||||||||||
|
The consequences of addiction among healthcare professionals (HCPs) are not limited to the usual problems we are well aware of in others with this disease. In the healthcare workplace patient harm is a real, preventable possibility. Addiction in this setting can undermine professional peer morale, and healthcare systems, clinics and hospitals can be at risk for legal retribution (Berge, K.H., Seppala, M.D. & Schipper, A.M., 2009). The nature of the healthcare workplace is unfamiliar to most counselors and treatment programs. Addiction among HCPs can result in great harm to the practitioner and to others, requiring programs and counselors that specialize in this area of addiction treatment. Counselors working with HCPs face unique challenges, but they also play a tremendous role in the remarkable outcomes of physicians with addiction. The Seattle Post Intelligencer reported the case of an anesthesiologist who was “diverting drugs from my patients” and described him as intoxicated with Demerol during surgery (Smith, C., 2003). A female patient was left in a “persistent vegetative state” (essentially a lasting coma) after the routine surgical procedure. The anesthesiologist stopped her oxygen while she was still paralyzed and could not breathe on her own. Both he and the hospital were sued and he entered addiction treatment. A surgical technician in Colorado was indicted last year after it was found that she had likely infected up to 5,700 people with Hepatitis C (Denver Post, 2009). At least 35 people have tested positive for Hepatitis C as a result of her actions. The surgical technician, who was addicted to heroin, stole and injected herself with syringes of fentanyl, refilled them with saline and replaced the contaminated syringes to be used on patients, resulting in patients being subjected to inadequate anesthesia, excess pain and exposure to Hepatitis C. While some claim these are sensational examples of rare events, the actual number of such events is undetermined. These horrific situations usually only get discussed when exposed by the patient, the family or the legal system, after the healthcare professional gets caught. Counselors cannot expect HCPs to admit to these indiscretions, and certainly not in a typical group setting. Addiction is a significant problem among HCPs. Accurate numbers are difficult to come by, but data from physician populations reveals that the rate of addiction during a physician’s career is estimated to be the same or somewhat higher than in the general population—10 to 12 percent (Hughes, P.H., Brandenburg, N., Baldwin, D.C. Jr., et al., 1992; McLellan, A.T., Skipper, G.S., Campbell, M. & DuPont, R.L., 2008). It is unknown whether the rate of addiction among nurses is any different than the general population (Maher-Brison, 2007). Compared to the general public, physicians are more likely to use prescribed medications, but the primary problem remains alcohol (50.3 percent) (McLellan, A.T., Skipper, G.S., Campbell, M. & DuPont, R.L., 2008). Anesthesiologists are the exception to this, in that the most common drug of abuse among this group is highly potent injected opioids, such as fentanyl/sufentanil, which are at least 100 times more powerful than heroin (Kintz, P., Villain, M., Dumestre, V. & Cirimele, V., 2005). In a study of 16 state physician health programs that examined 904 consecutive physicians placed under monitoring, five medical specialties comprised greater than half of the physicians: family medicine (20 percent), internal medicine (13.1 percent), anesthesiology (10.9 percent), emergency medicine (7.1 percent) and psychiatry (6.9 percent) (McLellan, A.T., Skipper, G.S., Campbell, M. & DuPont, R.L., 2008). Anesthesiologists comprise 5.2 percent of physicians nationwide; therefore, they are remarkably over-represented in physician health programs (American Medical Association, 2007). All HCPs need specialty treatment, but anesthesiologists, nurse anesthetists and other operating room personnel require special attention due to the dangers associated with diversion and use of the most powerful substances known. A university hospital referred one of its physicians to the state HCP program for evaluation after she was caught stealing opioids. Although the physician did not admit to having a problem, she agreed to enter a residential treatment program for evaluation. She drove from the office of the HCP program to her home in disgrace. There she gathered a large syringe of morphine with plans to kill herself rather than enter treatment. She sat in her car in the treatment program parking lot for an hour trying to decide whether or not to take her life. Fortunately, she chose to undergo the evaluation and save the morphine for later. Once involved in the program she divulged her plan, provided the morphine to staff and fully engaged in the recovery process. Most states have HCP programs for addicted physicians that are affiliated with the state medical board or the state medical association. However, many states do not provide the same level of intervention and monitoring for other HCPs, including nurses. Nurse anesthetists—with the same access to opioids as anesthesiologists—have no monitoring programs in many states. As a result, they are often undertreated, and many die as a result of their addictions. State physician programs emerged in the 1970s after the American Medical Association (AMA) recognized the extent of the addiction problem (AMA, 1973). Rapid confirmation that a substance-use problem may exist, with immediate intervention, prevent the potential for harm to patients, workplace complications and harm to the addicted healthcare worker. The hospital does not need evidence “beyond a reasonable doubt” to intervene, as personnel are not being accused of a crime (Berge, K.H., Seppala, M.D. & Schipper, A.M., 2009). Instead, they are undergoing a work-fitness evaluation seeking evidence of an illness, one the individual may be the last to fully recognize. Once confronted about the possibility of addiction the HCP may act desperately; thus, great care must be taken to prevent suicide or other adverse outcomes (Myers, M.F. & Gabbard, G.O., 2008). Addiction is a disease of the brain’s reward circuitry where the dysfunction is primarily in the limbic system and the pre-frontal cortex. Advances in the neurobiology of addiction have revealed supraphysiologic release of dopamine, establishing an excessive signal of reward by addictive substances (Kalivas, P.W. & Volkow, N.D., 2005). Pre-frontal inhibition of drug use secondary to conscious recognition of mounting consequences would be a normal response, but is undermined as limbic drives prevail. Survival itself is reprioritized and becomes secondary to the ongoing use of the drug (Hyman, S.E., 2005). This reprioritization explains how the addicted HCP can continue to use drugs while the potential adverse consequences mount. The use of the drug becomes paramount, and the damaged brain does not recognize consequences; it only strives for more of the drug. The addicted typically do not fully recognize their plight or the risks they are taking to continue drug use. The prominence of the new limbic drive for the drug recruits higher cortical centers, using the healthcare professional’s intelligence against themselves to preserve continued drug access and use. It should not be surprising that the addicted will deny use; bargain for situations that facilitate continued use; and even give up careers, family and sometimes life itself in the pursuit of the addictive substance. Treatment for addiction is rarely sought spontaneously. HCPs often resistant to treatment Unfortunately for the physician and other HCPs with addiction who are unable to recognize the problem, there are many reasons that peers and family do not identify or intervene early in the course of addiction. Medical schools provide few, if any, days of training in addiction, and the vast majority of primary care physicians have been shown to be unable to recognize and appropriately treat alcoholism (CASA, 2000; McGlynn, E.A., Asch, S.M., Adams, J., et al., 2003). Colleagues are hesitant to engage in another’s private affairs and will resist acting on a disease they have very little knowledge about Farber, N.J., Gilbert, S.G., Aboff, B.M., et al., 2005). Addiction can be misunderstood as a choice, not an illness, inhibiting action by others. There may be a “conspiracy of silence” in the workplace and the home, limiting any involvement on the part of friends, family and colleagues. If the practice is small, or the physician is in a position of power in a hospital or large clinic, other employees may fear for their jobs and careers if they mention the possibility of addiction. Family members may know of the addiction earlier than those in the workplace, but they could be hesitant to act for fear of financial consequences, loss of job, loss of prestige and loss of licensure. Fear of litigation can limit appropriate attention to this disease. Stigma and bias also interfere, as people often cannot believe a physician could have addiction or only believe addiction occurs in the lower socioeconomic classes (Talbott, G.D., 1982). Limited discussion of patient morbidity and mortality by HCPs in treatment programs is commonplace and may be legitimate, due to legally protected information that cannot be shared; but the culture of medicine also contributes to the lack of attention to clinical mistakes and adverse events in the healthcare workplace. Among physicians (especially surgeons) and other healthcare personnel there may be a credo that prevents emotional expression related to negative clinical outcomes. Such a culture also prevents discussion of personal problems and recognition and attention to addiction among colleagues. As a result, self doubt, guilt and shame are addressed only in isolation. These factors must be recognized by counseling staff, and addressed within the course of addiction treatment, which requires a safe, healing environment that fosters appropriate disclosure. HCP treatment programs must provide extensive, professional evaluations to establish an accurate diagnosis, determine potential co-occurring psychiatric problems, provide information for treatment planning, satisfy state HCP program requirements and establish a record for return to work decision making. Proper evaluation includes a physical examination, psychological and psychometric testing, an assessment of family functioning and a psychiatric evaluation. Physicians seldom enter treatment without coercion and will initially only rarely describe the history in an accurate manner secondary to both denial and conscious decision making. They recognize little incentive to admit to a drug problem and are afraid and anxious secondary to potential job loss and licensure issues (Talbott, G.D., 1982). They also are driven by the continued pursuit of powerfully reinforcing drugs that limit objective self-examination. Collateral information is essential to the diagnostic evaluation and may be the only way to obtain a history adequate to making an accurate initial diagnosis (Berge, K.H., Seppala, M.D. & Schipper, A.M., 2009). Most treatment programs specializing in HCPs require signed release of information forms or they will not complete these specialized evaluations or initiate treatment. Evaluation and treatment requires a multidisciplinary team with experience working with HCPs (Graham, A.W., Schultz, T.K., Mayo-Smith, M.F. Ries, R.K., Wilford, B.B., 2007). HCP treatment programs include group and individual psychotherapy, education about addiction, and skills training to prevent a return to drug and alcohol use (Berge, K.H., Seppala, M.D. & Schipper, A.M., 2009). They also emphasize fellowship and encourage physicians to learn from one another and re-establish positive relationships with a level of intimacy that helps with acceptance and healing. These programs require complete abstinence from alcohol and drugs, and the vast majority use a 12 Step model based on the principles of Alcoholics Anonymous. A recent study revealed that 95 percent of physicians were treated using a 12 Step model and 78 percent entered residential treatment for a mean of 72 days (range 30 to 90 days) (Kintz, P., Villain, M., Dumestre, V. & Cirimele, V., 2005). It is necessary to provide a milieu that establishes a safe place for physicians and other HCPs to become patients and to express themselves in a manner that allows for acceptance of addiction and pursuit of recovery. Group therapy with other HCPs breaks through some of the defenses that can limit self-examination and supports recognition of cues and triggers unique to the health-care setting. They have the opportunity to discuss the stressors associated with medical practice and their predicaments, including medical board involvement, legal issues and potential problems with the Drug Enforcement Administration. Most HCPs are tremendously ashamed of taking drugs from the workplace and injecting themselves and have great difficulty admitting to this. They often think of themselves as the only person who has ever diverted drugs for self-use. Group therapy with other addicted HCPs often results in admission of addictive behaviors and enhances acceptance. Addiction treatment is arranged to help people break the cycle of addictive behaviors and address associated problems that have usually gone unnoticed secondary to the numbing power of addictive drug use. Participants examine their relationships, their use of money, their families, their decision-making and other major life areas. Addiction can alter perspective so significantly that physicians often enter treatment convinced that their work or other stressors have caused drug use, only to realize, once sober and in recovery, they are very happy and proud to be doctors. Prior to completing treatment physicians and other HCPs should undergo a practice assessment to examine their ability to return to work. This assessment provides the opportunity to establish the risks of returning to practice, to determine a treatment plan supportive of abstinence in the workplace, to address relapse prevention and to initiate the decision-making about timing of return to practice (Berge, K.H., Seppala, M.D. & Schipper, A.M., 2009). Some physicians and other HCPs can go right back to the workplace, whereas others require further treatment or a period of abstinence prior to returning to work. Some will have to consider a different type of practice or another specialty. A very small group will not return to the practice of medicine. Return to work decisions are difficult and require the expertise of a treatment team well-versed in healthcare professional treatment and decision-making, the staff of the state HCP program, and the help of others in the medical workplace. Several factors predict relapse in HCPs, including: a positive family history for addiction/alcoholism; a psychiatric illness in addition to addiction; use of a major opioid and a psychiatric illness; and use of a major opioid, a psychiatric illness and a positive family history (Domino, K.B., Hornbein, T.F., Polissar, N.L., et al., 2005). This information is being used in treatment, monitoring and return-to-work decisions for addicted physicians. Anesthesiologists, nurse anesthetists and other operating room personnel who return to their prior workplace will be handling the very drugs they were addicted to, which is unlike almost all other addicted patients, and specifically includes the risks of cues and triggers associated with prior drug use. As a result, recommendations have been made to prevent their return to the operating room (Berge, K.H., Seppala, M.D. & Lanier, W.L., 2008). Currently a group, including the author, is working on a return-to-work decision making tool for anesthesiologists and nurse anesthetists that will help define expectations of the individual and the state monitoring program to standardize the decision-making and reduce relapse risk. Addiction is a relatively common illness and affects physicians at the same or slightly higher levels than the general population. Unfortunately, other HCPs do not receive the same treatment and monitoring in many states. Treatment in specialty programs designed for HCPs is necessary to address the issues unique to physicians and other healthcare personnel. Physicians have remarkable recovery rates when involved in appropriate treatment and monitoring programs. All medical personnel with exposure to powerfully addictive medications in the workplace should have access to HCP programs and monitoring systems to ensure appropriate treatment and the highest likelihood of successful abstinence and recovery. We can learn from the remarkable positive outcomes of physicians to improve the recovery rates of other HCPs as well as anyone with addiction.
Powered by !JoomlaComment 3.26
3.26 Copyright (C) 2008 Compojoom.com / Copyright (C) 2007 Alain Georgette / Copyright (C) 2006 Frantisek Hliva. All rights reserved."
|
||||||||||||||||||||||||||||||||||






